Literature DB >> 12109820

Dendritic cells for the immunotherapy of cancer.

Alan Melcher1, Andrew Bateman, Kevin Harrington, Atique Ahmed, Michael Gough, Richard Vile.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12109820     DOI： 10.1053/clon.2001.0038

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  2 in total

1.  Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy.

Authors:  Alison Merrick; Rosa Maria Diaz; Dearbhaile O'Donnell; Peter Selby; Richard Vile; Alan Melcher
Journal:  Cancer Immunol Immunother       Date:  2007-12-04       Impact factor: 6.968

2.  Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naive T-cell priming.

Authors:  A Merrick; F Errington; K Milward; D O'Donnell; K Harrington; A Bateman; H Pandha; R Vile; E Morrison; P Selby; A Melcher
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.